PIKing the next therapeutic target in multiple myeloma

Haematologica. 2020 Jun;105(6):1474-1475. doi: 10.3324/haematol.2020.248971.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / genetics
  • Phosphatidylinositol 3-Kinases

Substances

  • PIKFYVE protein, human